ZENAS BIOPHARMA INC (ZBIO) Stock Income Statement
NASDAQ:ZBIO - Nasdaq - US98937L1052 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | ||||
|---|---|---|---|---|---|---|
| Revenue | 5.00M | 50.00M | 0.00 | |||
| Operating Expenses | 168.89M | 77.15M | 75.20M | |||
| Research and Development | 139.14M | 60.03M | 61.69M | |||
| Selling, General, and Administrative Expenses | 29.75M | 17.11M | 13.51M | |||
| Operating Income | -163.89M | -27.15M | -75.20M | |||
| Other Income/Expense | 7.33M | 324.00K | -43.08M | |||
| Non Recurring Items | N/A | -10.00M | -1.00M | |||
| Income Before Taxes | -156.56M | -36.82M | -119.28M | |||
| Income Tax | 429.00K | 301.00K | 0.00 | |||
| Net Income | -156.99M | -37.12M | -119.28M | |||
| EBITDA | -163.75M | -27.03M | -75.12M | |||
| Per Share Data | ||||||
| EPS Diluted Total Ops | -11.89 | -0.93 | -3.00 | |||
| Statistics | ||||||
| Profit Margin | -3139.76% | -74.25% | N/A | |||
| Operating Profit Margin | -3277.76% | -54.29% | N/A | |||
All data in USD